Xu, Yufei

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell

Epigenetics and DNA MethylationChromatin Remodeling and Cancer

Cited by 789

Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer

Wu, D., Hu, D., Chen, H., Shi, G., Fetahu, I. S., Wu, F., Rabidou, K., Fang, R., Tan, L., Xu, S., et al. (2018) · Nature

Metabolism, Diabetes, and CancerEpigenetics and DNA Methylation

Cited by 477

Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development

Xu, Y., Xu, C., Kato, A., Tempel, W., Abreu, J. G., Bian, C., Hu, Y., Hu, D., Zhao, B., Cerovina, T., et al. (2012) · Cell

Epigenetics and DNA MethylationDevelopmental Biology and Gene Regulation

Cited by 271

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer

Yu, C., Luo, D., Yu, J., Zhang, M., Zheng, X., Xu, G., Wang, J., Wang, H., Xu, Y., Jiang, K., et al. (2022) · Oncogene

Colorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways

Cited by 70